Bioassay-guided Evaluation of Antinociceptive Effect of N-salicyloyltryptamine: A Behavioral and Electrophysiological Approach

Lucindo J Quintans Jr, Davi A Silva, Jullyana S Siqueira, Adriano A S Araújo, Rosana S S Barreto, Leonardo R Bonjardim, Josimari M Desantana, Waldeci De Lucca Jr, Maria F V Souza, Stanley J C Gutierrez, etc.

J Biomed Biotechnol. 2010;2010:230745.

PMID: 20976310


We investigated the antinociceptive and nerve excitability effects of the N-salicyloyltryptamine (NST) NST-treated mice exhibited a significant decrease in the number of writhes when 100 and 200 mg/kg (i.p.) were administered (i.p.). This effect was not antagonized by naloxone (1.5 mg/kg, i.p.). NST inhibited the licking response of the injected paw when 100 and 200 mg/kg were administered (i.p.) to mice in the first and second phases of the formalin test. Because the antinociceptive effects could be associated with neuronal excitability inhibition, we performed the single sucrose gap technique and showed that NST (3.57 mM) significantly reduced (29.2%) amplitude of the compound action potential (CAP) suggesting a sodium channel effect induced by NST. Our results demonstrated an antinociceptive activity of the NST that could be, at least in part, associated to the reduction of the action potential amplitude. NST might represent an important tool for pain management.

Copyright © 2022 Alfa Chemistry. All rights reserved.